Decreased NK cell numbers and impairment of NK cell function are reported in patients with multiple sclerosis (MS). Interleukin-7 (IL-7) is a member of the common gamma-chain (γc) cytokine superfamily that has well documented roles in lymphocyte development and homeostasis. The interleukin-7 receptor α chain (IL-7Rα) gene was identified as a top non-major histocompatibility complex-linked risk locus for MS. The objective of this study was to test biological function of IL-7/IL-7Rα on NK cells in MS patients. We observed markedly lower IL-7 levels in MS sera, and relatively higher IL-7Rα expression in NK cells of MS. Upon IL-7 stimulation, IL-7Rα on NK cells from MS patients was significantly down-regulated compared with healthy controls (HCs). IL-7 induced a higher increase of IFN-γ production in CD56
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Introduction
Natural killer (NK) cells are one component of the innate immune system and have the ability to both lyse target cells and provide an early source of immunoregulatory cytokines such as interferon-gamma (IFN-γ) (French and Yokoyama, 2004) et al., 2012b) in MS has been reported to demonstrate that this pathway may subsequently enhance the pathogenicity of these immune cells. The importance of this pathway for NK cell homeostasis is underlined by several studies in both healthy human and animals (Mazzucchelli and Durum, 2007; Michaud et al., 2010a; Lundstrom et al., 2012) ; however, its impact on NK cell function in MS has not yet been reported. The present study attempted to decipher in detail the impact of IL-7/ IL-7Rα signaling components on NK homeostasis and function in MS. We show that the serum IL-7 level is markedly lower and the expression of IL-7Rα on NK cells is significantly higher in MS patients. Upon IL-7 stimulation, IL-7Rα on NK cells from MS patients was significantly down-regulated compared with those from healthy controls (HCs). Moreover, IL-7 stimulation resulted in a higher enhanced cytotoxicity in NK cells and higher increased survival and IFN-γ production in CD56 bright NK subsets in MS patients. Our findings indicate that IL-7/ Journal of Neuroimmunology 276 (2014) 180-186
